GlaxoSmithKline Consumer Health Care New Zealand Limited
GlaxoSmithKline Consumer Health Care New Zealand Limited has been warned for likely breaching section 10 and 13(e) of the Fair Trading Act for misrepresentation as to the nature or characteristics of goods or their suitability for a purpose relating to Voltaren and Panadol products.
Case Details
Parties
GlaxoSmithKline Consumer Health Care New Zealand Limited
Category
Consumer
Sub-category
Act/Section
Fair Trading Act 1986 10, 13(e), 13(h)
Industry
Health care and social assistance
Status
Closed
Outcome
Warning letter
Case Number
Date opened
16 August 2017
Date closed
16 August 2017
Contact person